Connecticut (CT) Biotechnology Products and Services Companies

Featured companies
Recombinant Technologies LLC
25 Science Park
New Haven CT 06511
(203) 271-3125
In Ventiv Health Inc
574 Heritage Road
Southbury CT 06488
(203) 267-6930
Direct Medical Solutions Corp
5 Colby Way
Avon CT 06001

Direct Medical Solutions Corp. (DMS) is an innovative direct contract (CMO) product launch pharmaceutical, biotech and medical device sales company. W
Not satisfied? Select a reasonRate this pageSend feedback

Or try our search form or quick navigation by category and location

DKP Genomics
8 Merrywood Lane
East Lyme CT 06333
(860) 501-0228

A bioinformatics CRO and consultancy for bioinformatics analysis and infrastructure.
Global Search Solution
4 Grand Street
Bethel CT 068012112
(203) 798-2500

Global Search Solutions (GSS) is an agile, client-centric, retained search firm working exclusively in life sciences and healthcare
Axio Mx Inc
688 East Main St.
Branford CT 06405
(203) 208-1918
Cgi Pharmaceuticals Inc
36 East Industrial Road # 3
Branford CT 06405
(203) 315-5067
Recombinant Technologies
1090 Meriden Waterbury Turnpike # 1
Plantsville CT 06479
(203) 271-3125
Whereorg has 8 results under Biotechnology Products and Services Companies in Connecticut.

Select a location for category Biotechnology Products and Services


Top Stories
UBS flags buyback possibility after Second-quarter earnings beat
UBS , the world's largest wealth manager, on Tuesday signalled the possibility of resuming share buybacks later this year after generating more income than expected in the first six months and as it boosted...
Tue, Jul 21 2020
Greece calls EU recovery fund deal a 'national success'
Prime Minister Kyriakos Mitsotakis called a European Union deal on a post-pandemic recovery fund a "national success" that would allocate Greece around 72 billion euros ($82.38 billion) to help deal with...
Tue, Jul 21 2020
UBS second-quarter net profit dips as Swiss business dampens trading bonanza
UBS , the world's largest wealth manager, saw net profit drop 11% in the second quarter as higher trading activity failed to offset a pandemic-induced slump in retail and corporate banking.
Tue, Jul 21 2020